CAS 115607-61-9

Formel: C21H22N2O2

InChl: InChI=1S/C21H22N2O2/c1-4-8-18(24)16-13-22-21-15(10-7-12-19(21)25-3)20(16)23-17-11-6-5-9-14(17)2/h5-7,9-13H,4,8H2,1-3H3,(H,22,23)

InChI Key: MAVJDLHBPIXVJL-UHFFFAOYSA-N

SMILES: CCCC(=O)C1=CN=C2C(=C1NC3=CC=CC=C3C)C=CC=C2OC

SKF96067

CAS: 115607-61-9

SKF96067

Formel: C₂₁H₂₂N₂O₂

Reinheit: ≥98%

Molekulargewicht: 334.41

Ref: 54-BUP14102

SKF96067

CAS: 115607-61-9

Formel: C₂₁H₂₂N₂O₂

Reinheit: 99.89%

Molekulargewicht: 334.4116

Ref: IN-DA000G8J

3-Butyryl-4-(2-methylphenylamino)-8-methoxyquinoline

CAS: 115607-61-9

3-Butyryl-4-(2-methylphenylamino)-8-methoxyquinoline is an inhibitor of voltage-dependent calcium channels. It has been shown to inhibit the activity of p-hydroxybenzoic acid, which is a cell factor that regulates calcium levels in cells. 3-Butyryl-4-(2-methylphenylamino)-8-methoxyquinoline has been used in clinical pathology as an energy metabolism regulator and for the treatment of congestive heart failure by inhibiting voltage dependent calcium channels. This drug has also shown a protective effect on cancer tissues and some physiological effects, such as a reduction in hippocampal formation and pathogenic mechanism. The drug decreases mitochondrial membrane potential by interfering with the function of voltage dependent calcium channels, reducing ATP production and causing cell death.

Formel: C₂₁H₂₂N₂O₂

Reinheit: Min. 95%

Molekulargewicht: 334.4 g/mol

Ref: 3D-QEA60761

SKF96067

CAS: 115607-61-9

SKF96067 is a reversible gastric H+/K+-ATPase inhibitor that can induce relaxation of human airway smooth muscle in vitro.

Formel: C₂₁H₂₂N₂O₂

Reinheit: 99.89%

Farbe und Form: Yellow Solid

Molekulargewicht: 334.41

Ref: TM-T16894